0.3046
-0.0065
(-2.09%)
As of 8:00:48 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-84,081.0000
-155,006.0000
-135,341.0000
-82,153.0000
-66,350.0000
Investing Cash Flow
--
-20.0000
-139.0000
-445.0000
-316.0000
Financing Cash Flow
34,507.0000
26,522.0000
96,237.0000
102,447.0000
247,359.0000
End Cash Position
40,387.0000
65,221.0000
193,725.0000
232,968.0000
213,119.0000
Interest Paid Supplemental Data
--
7,551.0000
2,697.0000
40.0000
27.0000
Capital Expenditure
--
-20.0000
-139.0000
-445.0000
-316.0000
Issuance of Capital Stock
35,062.0000
27,032.0000
--
100,993.0000
255,785.0000
Issuance of Debt
--
--
98,600.0000
--
--
Repurchase of Capital Stock
--
--
--
--
-9,024.0000
Free Cash Flow
-84,081.0000
-155,026.0000
-135,480.0000
-82,598.0000
-66,666.0000
12/31/2020 - 3/12/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0M4.DU Mersana Therapeutics Inc
0.6000
+1.59%
8AW0.F Ocean Biomedical, Inc.
0.1710
-22.27%
2UV.F Applied Therapeutics, Inc.
0.5470
+6.21%
M55.F MacroGenics, Inc.
2.8800
-0.48%
1VT.DU Viking Therapeutics Inc
32.65
+1.56%
8AW0.BE Ocean Biomedical Inc
0.1910
+5.52%
3G0.BE Altimmune Inc
6.74
+0.42%
AT20.F Atara Biotherapeutics, Inc.
8.05
+8.05%
NV4.F Cellectar Biosciences, Inc.
0.2160
+8.00%
2UV.DU Applied Therapeutics Inc
0.5720
-0.44%